CGON
Price
$27.96
Change
+$5.59 (+24.99%)
Updated
Apr 28, 04:59 PM (EDT)
Capitalization
1.7B
10 days until earnings call
NUVL
Price
$75.13
Change
+$1.65 (+2.25%)
Updated
Apr 28, 04:59 PM (EDT)
Capitalization
5.26B
10 days until earnings call
Ad is loading...

CGON vs NUVL

Header iconCGON vs NUVL Comparison
Open Charts CGON vs NUVLBanner chart's image
CG Oncology
Price$27.96
Change+$5.59 (+24.99%)
Volume$43.36K
Capitalization1.7B
Nuvalent
Price$75.13
Change+$1.65 (+2.25%)
Volume$12.21K
Capitalization5.26B
CGON vs NUVL Comparison Chart
Loading...
CGON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NUVL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CGON vs. NUVL commentary
Apr 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CGON is a Buy and NUVL is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 29, 2025
Stock price -- (CGON: $22.37 vs. NUVL: $73.48)
Brand notoriety: CGON and NUVL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CGON: 163% vs. NUVL: 33%
Market capitalization -- CGON: $2.13B vs. NUVL: $5.38B
CGON [@Biotechnology] is valued at $2.13B. NUVL’s [@Biotechnology] market capitalization is $5.38B. The market cap for tickers in the [@Biotechnology] industry ranges from $272.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.13B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CGON’s FA Score shows that 0 FA rating(s) are green whileNUVL’s FA Score has 0 green FA rating(s).

  • CGON’s FA Score: 0 green, 5 red.
  • NUVL’s FA Score: 0 green, 5 red.
According to our system of comparison, NUVL is a better buy in the long-term than CGON.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CGON’s TA Score shows that 5 TA indicator(s) are bullish while NUVL’s TA Score has 6 bullish TA indicator(s).

  • CGON’s TA Score: 5 bullish, 4 bearish.
  • NUVL’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, NUVL is a better buy in the short-term than CGON.

Price Growth

CGON (@Biotechnology) experienced а +8.38% price change this week, while NUVL (@Biotechnology) price change was +2.57% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +11.19%. For the same industry, the average monthly price growth was +1.10%, and the average quarterly price growth was -9.09%.

Reported Earning Dates

CGON is expected to report earnings on May 08, 2025.

NUVL is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+11.19% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NUVL($5.26B) has a higher market cap than CGON($1.71B). NUVL YTD gains are higher at: -6.132 vs. CGON (-22.001). CGON has higher annual earnings (EBITDA): -95.94M vs. NUVL (-280.37M). NUVL has more cash in the bank: 1.12B vs. CGON (541M). CGON has higher revenues than NUVL: CGON (684K) vs NUVL (0).
CGONNUVLCGON / NUVL
Capitalization1.71B5.26B32%
EBITDA-95.94M-280.37M34%
Gain YTD-22.001-6.132359%
P/E RatioN/AN/A-
Revenue684K0-
Total Cash541M1.12B48%
Total Debt296KN/A-
TECHNICAL ANALYSIS
Technical Analysis
CGONNUVL
RSI
ODDS (%)
Bullish Trend 4 days ago
90%
Bullish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
86%
Momentum
ODDS (%)
Bullish Trend 4 days ago
62%
Bullish Trend 4 days ago
75%
MACD
ODDS (%)
Bullish Trend 4 days ago
50%
Bullish Trend 4 days ago
73%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
74%
Bullish Trend 4 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
85%
Bearish Trend 4 days ago
83%
Advances
ODDS (%)
Bullish Trend 4 days ago
71%
Bullish Trend 5 days ago
81%
Declines
ODDS (%)
Bearish Trend 21 days ago
88%
Bearish Trend 21 days ago
79%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
75%
Bullish Trend 4 days ago
81%
Aroon
ODDS (%)
Bearish Trend 4 days ago
85%
Bearish Trend 7 days ago
87%
View a ticker or compare two or three
Ad is loading...
CGON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NUVL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
EQL40.780.11
+0.27%
ALPS Equal Sector Weight ETF
BSMT22.470.03
+0.13%
Invesco BulletShares 2029 Muncpl Bd ETF
CHPS26.77N/A
N/A
Xtrackers Semiconductor Select Eq ETF
ITB91.26-0.89
-0.97%
iShares US Home Construction ETF
GOEX40.72-0.63
-1.54%
Global X Gold Explorers ETF

CGON and

Correlation & Price change

A.I.dvisor indicates that over the last year, CGON has been loosely correlated with SYRE. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if CGON jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CGON
1D Price
Change %
CGON100%
+3.95%
SYRE - CGON
53%
Loosely correlated
-5.36%
ACLX - CGON
51%
Loosely correlated
-0.41%
IDYA - CGON
50%
Loosely correlated
-0.37%
NUVL - CGON
49%
Loosely correlated
-0.68%
KRYS - CGON
48%
Loosely correlated
-0.63%
More

NUVL and

Correlation & Price change

A.I.dvisor indicates that over the last year, NUVL has been loosely correlated with ABCZF. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if NUVL jumps, then ABCZF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NUVL
1D Price
Change %
NUVL100%
-0.68%
ABCZF - NUVL
51%
Loosely correlated
N/A
ROIV - NUVL
47%
Loosely correlated
+0.09%
KYMR - NUVL
47%
Loosely correlated
-0.89%
RVMD - NUVL
44%
Loosely correlated
+0.49%
CRNX - NUVL
44%
Loosely correlated
-2.99%
More